DATATOPDeprenyl and Tocopherol Antioxidative Therapy of Parkinsonism
References in periodicals archive ?
Scientists at Massachusetts General Hospital and the Harvard School of Public Health and including physicians at the University of Rochester Medical Center, led the study, which was based on a landmark study known as DATATOP, which was conducted two decades ago.
However, in the DATATOP study, it did not affect the probability that the patient would need levodopa.
The DATATOP study in the USA revealed that (-)-deprenyl delayed the onset of disability associated with early, otherwise untreated Parkinson's disease.